PRODUCT OVERVIEW
About SEGIPRED® Inj 500
It may be used for acute inflammatory, allergic, and immune-mediated conditions when clinically appropriate. Its administration should be guided by qualified healthcare professionals, based on the patient’s condition, clinical assessment, and approved prescribing information.
Composition & Therapeutic Profile
SEGIPRED® Inj 500 is a methylprednisolone sodium succinate injection formulated for clinical situations requiring systemic corticosteroid therapy, as indicated by qualified healthcare professionals.
Composition
Methylprednisolone Sodium Succinate for Injection USP.
Therapeutic Class
Systemic corticosteroid.
Therapeutic Focus
Selected inflammatory and immune-mediated conditions.
How SEGIPRED® Inj 500 Works
Methylprednisolone is a synthetic glucocorticoid that acts by binding to intracellular glucocorticoid receptors. This interaction influences gene transcription and regulates the production of inflammatory mediators, helping produce anti-inflammatory and immunomodulatory effects. Its clinical effects depend on the condition being treated and the prescribed treatment regimen.
Receptor Binding
Binds to intracellular glucocorticoid receptors.
Gene Regulation
Influences the expression of genes involved in inflammatory responses.
Therapeutic Effects
Produces anti-inflammatory and immunomodulatory effects.
Clinical & Therapeutic Areas
Methylprednisolone sodium succinate may be used in selected inflammatory, allergic, and immune-mediated conditions when systemic corticosteroid therapy is clinically indicated. Use should be guided by the approved prescribing information and assessment by qualified healthcare professionals.
Inflammatory Conditions
Systemic corticosteroid therapy for selected acute inflammatory conditions, as indicated by the approved prescribing information.
Allergic Conditions
May be considered in selected allergic conditions when systemic corticosteroid treatment is clinically appropriate.
Immune-Mediated Conditions
May be used to help manage selected immune-mediated disorders when corticosteroid therapy is indicated.
Frequently Asked Questions
SEGIPRED® Inj 500 is a parenteral corticosteroid formulation containing methylprednisolone sodium succinate. It is used in selected clinical situations where systemic corticosteroid therapy is indicated.
It is a corticosteroid used to manage selected inflammatory, allergic and immune-mediated conditions, depending on the clinical indication and approved prescribing information.
It binds to intracellular glucocorticoid receptors and influences gene expression, producing anti-inflammatory and immunomodulatory effects.
No. Injectable corticosteroid treatment should be administered by qualified healthcare professionals according to the approved prescribing information.
Relevant considerations include infection risk, blood glucose, blood pressure, other medical conditions and concomitant medicines. A healthcare professional should assess individual risks before treatment.
Discover Our Specialty Pharmaceutical Portfolio
Explore the MERGA and PRINCEPS divisions of Seginus Pharma and discover our portfolio of pharmaceutical products across key therapeutic areas.
